Keywords: sanofi, uroxatral, available, usa, sanofi-synthelabo, launched, alfuzosin
Sanofi's Uroxatral available in the USA
Article | 10 November 2003
Sanofi-Synthelabo has launched Uroxatral (alfuzosin hydrochlorideextended-release tablets) in the USA. The product is a 10mg once-daily treatment indicated for relief ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
